Evommune, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.evommune.com
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
- Conditions
- Chronic Spontaneous Urticaria
- Interventions
- Drug: Placebo control
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06873516
- Locations
- 🇺🇸
Cahaba Dermatology Skin Health Center, Birmingham, Alabama, United States
🇺🇸Velocity Clinical Research, Mobile, Mobile, Alabama, United States
🇺🇸Center for Dermatology Clinical Research, Fremont, California, United States
Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
- Conditions
- Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
- Interventions
- Biological: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06723405
- Locations
- 🇦🇺
Cornerstone Dermatology, Coorparoo, Australia
🇦🇺Momentum Clinical Research Darlinghurst, Darlinghurst, Australia
🇳🇿Pacific Clinical Research Network (PCRN) Auckland, Auckland, New Zealand
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
- Conditions
- Chronic Inducible Urticaria
- Interventions
- Drug: Oral EVO756
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06603220
- Locations
- 🇺🇸
Cahaba Dermatology & Skin Health Center, LLC, Birmingham, Alabama, United States
🇺🇸California Allergy and Asthma Medical Group, Los Angeles, California, United States
🇺🇸Integrative Skin Science and Research, Sacramento, California, United States
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT05579899
- Locations
- 🇺🇸
Saguaro Dermatology, Phoenix, Arizona, United States
🇺🇸Clinical Trials Institute of Northwest Arkansas, Fayetteville, Arkansas, United States
🇺🇸Northwest AR Clinical Trials Center, PLLC, Rogers, Arkansas, United States